Annual EBITDA:
-$108.62M+$12.08M(+10.01%)Summary
- As of today, ZYME annual EBITDA is -$108.62 million, with the most recent change of +$12.08 million (+10.01%) on December 31, 2024.
- During the last 3 years, ZYME annual EBITDA has risen by +$97.47 million (+47.29%).
- ZYME annual EBITDA is now -176.23% below its all-time high of $142.49 million, reached on December 31, 2022.
Performance
ZYME EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$19.53M-$22.07M(-868.74%)Summary
- As of today, ZYME quarterly EBITDA is -$19.53 million, with the most recent change of -$22.07 million (-868.74%) on September 30, 2025.
- Over the past year, ZYME quarterly EBITDA has increased by +$12.02 million (+38.10%).
- ZYME quarterly EBITDA is now -106.07% below its all-time high of $321.70 million, reached on December 31, 2022.
Performance
ZYME Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$57.82M+$12.02M(+17.21%)Summary
- As of today, ZYME TTM EBITDA is -$57.82 million, with the most recent change of +$12.02 million (+17.21%) on September 30, 2025.
- Over the past year, ZYME TTM EBITDA has increased by +$52.35 million (+47.52%).
- ZYME TTM EBITDA is now -126.16% below its all-time high of $221.03 million, reached on September 30, 2023.
Performance
ZYME TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ZYME EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +10.0% | +38.1% | +47.5% |
| 3Y3 Years | +47.3% | +59.5% | +73.5% |
| 5Y5 Years | +24.1% | +72.5% | +72.9% |
ZYME EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -176.2% | +47.3% | -106.1% | +60.6% | -126.2% | +73.5% |
| 5Y | 5-Year | -176.2% | +47.3% | -106.1% | +72.5% | -126.2% | +75.0% |
| All-Time | All-Time | -176.2% | +47.3% | -106.1% | +72.6% | -126.2% | +75.0% |
ZYME EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$19.53M(-868.7%) | -$57.82M(+17.2%) |
| Jun 2025 | - | $2.54M(+111.4%) | -$69.84M(+26.8%) |
| Mar 2025 | - | -$22.31M(-20.4%) | -$95.45M(+12.1%) |
| Dec 2024 | -$108.62M(+10.0%) | -$18.53M(+41.3%) | -$108.63M(+1.4%) |
| Sep 2024 | - | -$31.54M(-36.7%) | -$110.17M(-4.6%) |
| Jun 2024 | - | -$23.07M(+35.0%) | -$105.33M(+20.1%) |
| Mar 2024 | - | -$35.49M(-76.8%) | -$131.86M(-9.2%) |
| Dec 2023 | -$120.70M(-184.7%) | -$20.07M(+24.8%) | -$120.75M(-154.6%) |
| Sep 2023 | - | -$26.70M(+46.2%) | $221.03M(+10.8%) |
| Jun 2023 | - | -$49.60M(-103.4%) | $199.56M(+7.6%) |
| Mar 2023 | - | -$24.38M(-107.6%) | $185.51M(+30.2%) |
| Dec 2022 | $142.49M(+169.1%) | $321.70M(+767.9%) | $142.53M(+165.2%) |
| Sep 2022 | - | -$48.16M(+24.3%) | -$218.58M(+4.4%) |
| Jun 2022 | - | -$63.65M(+5.5%) | -$228.62M(+1.1%) |
| Mar 2022 | - | -$67.36M(-70.9%) | -$231.09M(-12.2%) |
| Dec 2021 | -$206.09M(-16.3%) | -$39.41M(+32.3%) | -$206.05M(-2.2%) |
| Sep 2021 | - | -$58.20M(+12.0%) | -$201.66M(+6.0%) |
| Jun 2021 | - | -$66.13M(-56.3%) | -$214.48M(-15.0%) |
| Mar 2021 | - | -$42.31M(-20.8%) | -$186.44M(-5.2%) |
| Dec 2020 | -$177.17M | -$35.02M(+50.7%) | -$177.19M(+17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$71.02M(-86.5%) | -$213.42M(-22.4%) |
| Jun 2020 | - | -$38.08M(-15.2%) | -$174.29M(-6.7%) |
| Mar 2020 | - | -$33.06M(+53.6%) | -$163.29M(-13.9%) |
| Dec 2019 | -$143.19M(-381.6%) | -$71.25M(-123.4%) | -$143.31M(-129.7%) |
| Sep 2019 | - | -$31.90M(-17.8%) | -$62.40M(-27.3%) |
| Jun 2019 | - | -$27.08M(-106.9%) | -$49.02M(-111.3%) |
| Mar 2019 | - | -$13.09M(-235.4%) | -$23.20M(+21.4%) |
| Dec 2018 | -$29.73M(-472.6%) | $9.67M(+152.2%) | -$29.50M(-479.9%) |
| Sep 2018 | - | -$18.52M(-1373.3%) | -$5.09M(-99.7%) |
| Jun 2018 | - | -$1.26M(+93.5%) | -$2.55M(+74.1%) |
| Mar 2018 | - | -$19.39M(-156.9%) | -$9.83M(-108.2%) |
| Dec 2017 | -$5.19M(+85.9%) | $34.08M(+313.3%) | -$4.72M(+90.4%) |
| Sep 2017 | - | -$15.98M(-87.0%) | -$49.25M(-9.5%) |
| Jun 2017 | - | -$8.54M(+40.2%) | -$44.97M(-4.1%) |
| Mar 2017 | - | -$14.28M(-36.7%) | -$43.18M(-17.0%) |
| Dec 2016 | -$36.91M(-98.2%) | -$10.45M(+10.6%) | -$36.91M(-39.5%) |
| Sep 2016 | - | -$11.69M(-73.1%) | -$26.46M(-79.2%) |
| Jun 2016 | - | -$6.75M(+15.7%) | -$14.77M(-84.3%) |
| Mar 2016 | - | -$8.01M | -$8.01M |
| Dec 2015 | -$18.62M(-48.7%) | - | - |
| Dec 2014 | -$12.52M | - | - |
FAQ
- What is Zymeworks Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Zymeworks Inc.?
- What is Zymeworks Inc. annual EBITDA year-on-year change?
- What is Zymeworks Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Zymeworks Inc.?
- What is Zymeworks Inc. quarterly EBITDA year-on-year change?
- What is Zymeworks Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Zymeworks Inc.?
- What is Zymeworks Inc. TTM EBITDA year-on-year change?
What is Zymeworks Inc. annual EBITDA?
The current annual EBITDA of ZYME is -$108.62M
What is the all-time high annual EBITDA for Zymeworks Inc.?
Zymeworks Inc. all-time high annual EBITDA is $142.49M
What is Zymeworks Inc. annual EBITDA year-on-year change?
Over the past year, ZYME annual EBITDA has changed by +$12.08M (+10.01%)
What is Zymeworks Inc. quarterly EBITDA?
The current quarterly EBITDA of ZYME is -$19.53M
What is the all-time high quarterly EBITDA for Zymeworks Inc.?
Zymeworks Inc. all-time high quarterly EBITDA is $321.70M
What is Zymeworks Inc. quarterly EBITDA year-on-year change?
Over the past year, ZYME quarterly EBITDA has changed by +$12.02M (+38.10%)
What is Zymeworks Inc. TTM EBITDA?
The current TTM EBITDA of ZYME is -$57.82M
What is the all-time high TTM EBITDA for Zymeworks Inc.?
Zymeworks Inc. all-time high TTM EBITDA is $221.03M
What is Zymeworks Inc. TTM EBITDA year-on-year change?
Over the past year, ZYME TTM EBITDA has changed by +$52.35M (+47.52%)